Skip to main content
Surgical Science Sweden AB (publ) (STO:SUS)
Sweden flag Sweden · Delayed Price · Currency is SEK
32.92
-0.48 (-1.44%)
Apr 28, 2026, 5:29 PM CET

STO:SUS Revenue

In the year 2025, Surgical Science Sweden AB had annual revenue of 992.34M SEK with 12.25% growth. Surgical Science Sweden AB had revenue of 268.85M in the quarter ending December 31, 2025, with 6.88% growth.

Revenue
992.34M
Revenue Growth
+12.25%
P/S Ratio
1.69
Revenue / Employee
3.17M
Employees
328
Market Cap
1.68B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025992.34M108.26M12.25%
Dec 31, 2024884.09M1.23M0.14%
Dec 31, 2023882.85M80.31M10.01%
Dec 31, 2022802.54M435.76M118.81%
Dec 31, 2021366.78M261.98M249.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 28.24B
Getinge AB 34.09B
Sectra AB 3.52B
Camurus AB 2.27B
Saniona AB 434.40M
Cereno Scientific AB 44.27M
Carasent AB 349.05M
Devyser Diagnostics AB 250.50M
Revenue Rankings

Surgical Science Sweden AB News

More News